Synapse - Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center

Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center Meeting Abstract

Authors:	Silverman, E. A.; Hubbeling, H.; Palomba, M. L.; Wijetunga, N. A.; Tringale, K.; Lebow, E.; Tomas, A. A.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Dahi, P. B.; Giralt, S. A.; Lin, R. J.; Park, J. H.; Scordo, M.; Sauter, C. S.; Shah, G. L.; Perales, M. A.; Hajj, C.; Yahalom, J.; Imber, B. S.
Abstract Title:	Five-year experience using bridging radiotherapy prior to chimeric antigen receptor (CAR) T-cell therapies for B-cell malignancies at Memorial Sloan Kettering Cancer Center
Meeting Title:	63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	138
Issue:	Suppl. 1
Meeting Dates:	2021 Dec 11-14
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2021-11-23
Language:	English
ACCESSION:	WOS:000736413902024
DOI:	10.1182/blood-2021-151179
PROVIDER:	wos
Notes:	Meeting Abstract: 2507 -- Hybrid meeting, also took place online -- Source: Wos